Apex Peptides is not taking orders: what we found (2026)
What Apex Peptides publishes about its catalogue, its lab reports, its shipping and its payment terms, read from apexpeptides.com on September 16, 2026and checked against FDA's warning letter database. A listing is not an endorsement, and we do not verify purity, identity or what is in any individual vial.
This page reports what published studies found. It is not medical advice, no provider-patient relationship is created by reading it, and nothing here is a recommendation to use any compound. Talk with a licensed clinician about your own situation. Read the full disclaimer.
At a glance
| Status | Pausedsince September 16, 2026 The site serves a maintenance notice instead of a storefront. On 2026-09-16 apexpeptides.com returned a single page reading "Maintanance | Technical break" in ten languages, tagged noindex, with an administrator login link and no catalogue. Its product sitemap returns the same page. |
|---|---|
| Lab reports | Not published We could not confirm a certificate policy from the pages we could read. |
| Ships to | Not published |
| Payment | Not published |
| FDA warning letters | None found in FDA's warning letter database when we searched it on September 16, 2026. |
| Website | apexpeptides.com |
Apex Peptides is not currently taking orders (checked September 14, 2026).
The storefront serves only a maintenance notice; no catalogue was reachable when checked.
Alternatives: Core Peptides, Biotech Peptides, Liberty Peptides.
Compounds listed
Products this vendor lists that match a compound we track, read from its own catalogue. Coded or abbreviated product names are not mapped, because that would mean guessing at what is in the vial.
No catalogue was readable when we checked, so no compounds are recorded for this vendor. Every compound profile carries its own regulatory status regardless of who sells it.
What we found
Apex Peptides is not taking orders. On 2026-09-16 the domain served a one-line maintenance notice, repeated in ten languages, alongside a WordPress administrator login link. The page carries a noindex tag, and requests for the product sitemap return the same holding page rather than a catalogue.
A maintenance page is not a closure announcement, and sites do come back. But there is no catalogue, no certificate information, no shipping or payment terms and no statement about open orders, so there is nothing for a reader to evaluate and no way to reach support through the site.
Apex Peptides did not appear in FDA's warning letter database when we searched it on 2026-09-16. We will update this page if the storefront returns; until then the open vendors on this page are the only ones with readable terms.
What “research use only” means, and the market it sits in
Every vendor in this section sells material labelled for research, laboratory or analytical use and not for human consumption. That label is not a formality and it is not a loophole. It is the seller stating that the product has not been through the approval or compounding systems that govern medicines, and that it is not intended for a person.
The market is under active enforcement. FDA's public warning letter database shows a continuing run of unapproved-new-drug and misbranding letters to peptide sellers: Gram Peptides and Pink Pony Peptides on 31 March 2026, Wholesale Peptide on 17 June 2026, and five on a single day, 24 August 2026, to Peak Performance Peptides, Royal Peptides, NuScience Peptides, Peptide Partners and Tex Peptides. Of the vendors profiled here, one appears in that database: Swiss Chems, letter dated 10 December 2024.
Criminal exposure is real as well. In the Northern District of Indiana, the operators of Paradigm Peptides entered guilty pleas on 10 December 2025 over products sold as SARMs that in fact contained testosterone and over unapproved peptide and hCG products; both were sentenced in July 2026. Separately, payment processors have been withdrawing from this category, which is why so many storefronts route buyers to crypto, Zelle or bank wire rather than a card.
There is a lawful route for several of these compounds, and it is not this one. At its meeting on 23–24 July 2026, FDA's Pharmacy Compounding Advisory Committee voted to recommend BPC-157, KPV and TB-500 (8–6, one abstention) and MOTS-c (7–5, two abstentions) for the section 503A bulk drug substances list. That vote is advisory: FDA decides, and where compounding proceeds it runs through a licensed prescriber and a licensed pharmacy, not a research storefront.
Sources for this section
- FDA warning letter database (searched 16 September 2026)
- FDA warning letter to Swisschems, 10 December 2024 (MARCS-CMS 695663)
- FDA warning letter to Gram Peptides, 31 March 2026
- FDA warning letter to Peak Performance Peptides, 24 August 2026
- United States v. Matthew Kawa, N.D. Indiana (guilty pleas entered 10 December 2025)
- FDA Pharmacy Compounding Advisory Committee, 2026 meeting materials (meeting of 23–24 July 2026)
Compound profiles carry the regulatory status for each substance, and online peptide therapy covers the prescription route.
Frequently asked questions
Is Apex Peptides still operating?
Not visibly. On 2026-09-16 the site served only a maintenance notice with an administrator login link and no catalogue. We record that as paused rather than closed, because no closure was announced.
Did Apex Peptides shut down?
No shutdown notice has been published. The difference matters: Peptide Sciences posted an explicit closure notice in March 2026, and Apex Peptides has posted nothing, so its state is unresolved rather than final.
What do Apex Peptides reviews say?
There is no live storefront to evaluate, so any current review of the shopping experience is describing something that is not there. We do not aggregate reviews for research vendors in any case.
Does Apex Peptides have a discount code?
There is no storefront to apply one to. We do not issue codes for any vendor listed here.
What should a reader do with an open Apex Peptides order?
The maintenance page offers no support route and says nothing about open orders. Anyone in that position is left with their payment provider's dispute process, which is the practical risk of a research vendor going dark.
Want it prescribed instead?
Nothing on this page is a route to a peptide for a person. The lawful route runs through a licensed prescriber and a licensed pharmacy, and for several of these compounds it exists today. Our telehealth section compares programs on prescriber type, pharmacy model, whether labs are required, state coverage and published pricing, and each compound profile states what can lawfully be prescribed or compounded right now.
Where the research stands
Our research digests summarise new studies against their primary sources, and are peptides legal explains the difference between an approved drug, a compounded preparation and a research chemical.